Maximum Weight Loss Potential (Future)# Recommendation : Amycretin Reason : Phase 1b/2a showed up to 24.3% weight loss at 36 weeks with no plateau, suggesting even greater loss with longer treatment
Dual Agonists : Drugs that activate two different receptors simultaneously (e.g., GLP-1 and GIP receptors) to enhance therapeutic effects, such as improved glycemic control and weight loss
Retatrutide, a new weight loss drug from Eli Lilly, shows promising results in clinical trials, but its not yet available
Quicksilver doesn't ship internationally but has distribution centers in several countries
Additionally, research in children found that magnesium supplementation significantly improved post-concussive symptoms like headache, fatigue, and concentration difficulties when compared to placebo (23)